APOE and Alzheimer disease: Some proteins, such as SPC25 and LRRN1, showed no difference between AD and Controls but exhibited dose-dependent associations with APOE ε4 (Fig. 3b), suggesting that previously identified links to AD from Vignette 1’s differential abundance analysis were driven by APOE ε4 enrichment in AD cases.